Christopher M. Jewell - 03 Jan 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell
Issuer symbol
RNAC
Transactions as of
03 Jan 2025
Net transactions value
-$42,783
Form type
4
Filing time
07 Jan 2025, 20:05:21 UTC
Previous filing
06 Jan 2025
Next filing
13 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale $21,136 -1,264 -2.3% $16.72 54,776 03 Jan 2025 Direct F1
transaction RNAC Common Stock Sale $21,646 -1,286 -2.3% $16.83 53,490 06 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.